NASDAQ · RAPP
Rapport Therapeutics, Inc.
Smart money pulse
What insiders and funds are doing
- group1 insider bought in the last 30 days. $20.4M in open-market buys, Oct 28.
- account_balance84 funds bought, 58 sold in the quarter ended Jun 30, 2026. 31 were new holders.
- infoNo real insider sales in 12 months. Planned 10b5-1 sales and tax withholding are left out.
Pulse runs from −100 (everyone selling) to +100 (everyone buying). Half comes from insiders: real buyers vs. real sellers in the last 90 days (Form 4). Half comes from funds: funds that bought vs. funds that sold last quarter (13F). 13F is a snapshot of long positions on the last day of the quarter, filed up to 45 days later. It does not show short positions or trades since then. This is data, not advice.
Who owns it
162 funds report owning RAPP , up from 146
Last quarter
Who bought and who sold
Change in shares held, biggest funds first. Bars stop at ±100%.
Insider trades · last 12 months
Real buys and sales
Showing 1 real trades. Bigger dot means a bigger trade.
Showing every filing. Dashed circles are routine: grants, tax withholding, option exercises and planned sales.
Top holders
Biggest funds in RAPP
| Fund | Owns | Value | Change |
|---|---|---|---|
| Fmr LLC | — | $299M | +0% |
| Trv Gp V, LLC | — | $262M | −12% |
| ARCH Venture Management, LLC | — | $155M | +0% |
| Capital International Investors | — | $122M | −6% |
| Goldman Sachs Group INC | — | $121M | −1% |
"Owns" is shares reported divided by shares outstanding.